New · GLP-1 pills · From $149/moLearn more
clyne
Concierge
TREATMENTS → HAIRREGROWTH · 6-MONTH PROTOCOLFDA-APPROVED MOLECULES
01 — REGROWTH

Stop
receding.
Start regrowing.

Finasteride, minoxidil, and — where indicated — oral dutasteride. A physician-written protocol, backed by regular check-ins. Ask Clyne Concierge anything about your treatment — it translates the clinical details into plain English.

BY MONTH 12

The density curve actually moves.

Standardized scalp photos every 30 days. Our vision model measures density, terminal ratio, and shaft diameter — the three numbers a dermatologist would.

DENSITY · TOP 80 cm²
+0%
BASELINE
+22%
MO 3
+46%
MO 6
+64%
MO 12
Based on common member-reported experiences. Individual results vary.
02 — THE MOLECULES
Finasteride 1mg
Oral · daily

Blocks 5α-reductase, cuts scalp DHT ~70%.

FROM$18/mo
Minoxidil 5%
Topical or oral

Extends anagen phase. Thicker shaft diameter.

FROM$22/mo
Dutasteride 0.5mg
Off-label · physician approval

Stronger DHT block. For non-responders to fin.

FROM$58/mo
03 — PROGRESS, OBJECTIVELY

The AI counts every follicle.

Snap a standardized scalp photo every 30 days. Our vision model measures density, terminal ratio, and shaft diameter — the three numbers a dermatologist would. Your physician sees the trend before your next check-in.

  • Density · follicles per cm²
  • Terminal ratio · thick vs. vellus
  • Shaft diameter · µm
MONTH 042 f/cm²
MONTH 678 f/cm²
Generic finasteride from $0.60/dayOral or topical minoxidilStandardized photos every 90 daysPhysician-reviewed progress checkPrescriber chatCompounded combinationsQuarterly bloodwork on dutGeneric finasteride from $0.60/dayOral or topical minoxidilStandardized photos every 90 daysPhysician-reviewed progress checkPrescriber chatCompounded combinationsQuarterly bloodwork on dutGeneric finasteride from $0.60/dayOral or topical minoxidilStandardized photos every 90 daysPhysician-reviewed progress checkPrescriber chatCompounded combinationsQuarterly bloodwork on dut
MEMBER · ANONYMIZED
Member, 0
ILLUSTRATIVE · 12-month protocol
OUTCOME
Trial-data baseline: ~90% of users on finasteride show visual improvement or stabilization at 5 years (Kaufman, JAAD 1998). Individual results vary.
MONTH 0

Baseline photo + scalp assessment.

A standardized progress photo from above, ring light, ruler at the temple — the photo gives your physician a measurable baseline to compare against. Density and recession pattern are documented as part of intake.

Baseline · standardized photo
MONTH 1

Finasteride 1 mg + topical minoxidil 5%.

Your physician reviews the photo and intake history (family history, libido baseline, medication interactions, prior treatments) and writes the protocol. The first month is mostly the shedding phase — a normal physiologic reset documented in Kaufman 1998 and Olsen 2002.

Standard regimen started
MONTH 3

Shedding tapers. Holding the line.

Per the trial literature, shedding typically tapers around week 9. Density usually stays close to baseline through the first quarter — the goal of months 1–3 is to stop the loss before pushing for visible regrowth.

Stabilization phase
MONTH 6

Vellus-to-terminal conversion.

Olsen 2002 reported mean density gains of ~18 hairs/cm² at 24 weeks with topical minoxidil 5%. Visible thickening and longer terminal hairs are the most common 6-month signal. Individual results vary.

Visible regrowth phase
MONTH 9

Side-effect check-in.

Sexual side effects in the controlled finasteride trials affect 1–2% of users and typically resolve when the drug is stopped. Your physician reviews your progress and either continues the protocol or discusses escalation (dutasteride per Jung 2014, oral minoxidil, or compounded combinations).

MONTH 12

Annual review.

Kaufman 1998 reported 90% of men experienced visual improvement or stabilization on finasteride at 5 years. The combo regimen (Hu Dermatol Ther 2015) outperformed monotherapy. Maintenance plan and re-photo cadence are set with your physician at this point.

Annual review · maintenance plan
04 — WHAT IT COSTS

Plain pricing. No surprise fees.

One subscription. Cancel any time. Labs, follow-ups, and Clyne Concierge included.

ORAL FIN
$18/ month
Cancel any time
Finasteride 1 mg daily. The proven floor.
  • Generic finasteride from US pharmacy
  • Quarterly photo review
  • Side-effect monitoring
  • Free dose pause / restart
Start oral fin
FIN + MIN
$36/ month
MOST POPULAR
Finasteride 1 mg + minoxidil 5%. The standard regimen.
  • Oral or topical minoxidil
  • Standardized progress photos every 90 days
  • Compounded combination available
  • Direct chat with prescriber
Start the combo
DUT + MIN
$72/ month
Requires intake review
Dutasteride for fin non-responders.
  • Off-label dutasteride 0.5 mg
  • Quarterly bloodwork
  • Specialist dermatology review
  • Compounded topicals included
Talk to a derm
06 — WHO PRESCRIBES

Real doctors. Not a chatbot in a lab coat.

Every prescription is signed by a US-licensed physician on staff. They review the AI summary, the intake, and the bloodwork — then make the call.

Your physician
US-licensed, board-certified

Your physician is US-licensed, board-certified, and reviews every case personally.

50 STATE LIC.
06 — EVIDENCE

The dermatology literature. Cited.

01
Finasteride 1 mg in androgenic alopecia — long-term study
Kaufman et al. — finasteride 1 mg/day produced clinically and statistically significant improvement in scalp hair count and patient self-assessment versus placebo through 2 years; the foundational evidence base for oral fin in male-pattern hair loss.
02
Topical minoxidil 5% twice-daily in men with AGA
Olsen et al. — 5% topical minoxidil produced superior hair counts at 48 weeks vs. 2% and vs. placebo. Initial shedding 23% and resolved by week 12.
03
Topical minoxidil foam 5% for AGA
Olsen et al. — minoxidil foam vehicle non-inferior to solution with improved tolerability; demonstrated treatment effect through 16 weeks.
04
Dutasteride 0.5 mg/day — Phase III in AGA
Jung et al. — dutasteride 0.5 mg/day superior to finasteride 1 mg/day on hair count and ratings at 24 weeks. Side-effect profile broadly similar.
05
5-AR inhibitor safety profile — systematic review
Hirshburg et al. — persistent sexual side effects after discontinuation reported in approximately 0.8–1.4% of users. Mechanism remains unclear; baseline screening recommended.
06
Combination finasteride + minoxidil therapy
Hu et al. — 94% of patients on combination fin + min therapy showed improvement at 12 months, outperforming either agent alone.
07 — WHEN WE WON'T PRESCRIBE

The honest list.

About 14% of hair intakes get redirected. Better to skip the script than write the wrong one.

Trying to conceive (you or partner)
Finasteride is teratogenic and dutasteride is metabolized slowly. We pause prescriptions during a conception window.
History of male breast cancer
Both 5-α reductase inhibitors are contraindicated. We don't write the script.
Severe depression or untreated anxiety
PFS literature is small but real. We coordinate with your psychiatrist before starting.
Pre-existing sexual dysfunction
We address that first. Adding finasteride before establishing baseline confounds the picture.
Cardiovascular contraindications to oral minoxidil
Pericardial disease, recent MI, or uncontrolled BP — we use topical instead.
Active scalp infection or active alopecia areata
Wrong tool. Routes to dermatology for diagnosis first.
08 — FREQUENTLY ASKED

The questions every member asks. Answered straight.

Months 1–3 are the holding phase: shedding pauses, density typically stays flat. Months 4–6 are the visible regrowth phase. Most members see what they were hoping to see between months 6 and 9. If nothing has happened by month 9, your physician will discuss escalation (dutasteride, oral minoxidil, or compounded combinations).

In the controlled trials, sexual side effects affect 1–2% of users and resolve when the drug is stopped. There's a smaller cohort (PFS, ~0.8–1.4%) who report persistent symptoms after discontinuation. We screen for risk factors before prescribing and we don't downplay it. If anything feels off, we want to know.

You can. Minoxidil alone gives modest density gains and doesn't address the underlying DHT cause, so it tends to plateau. The combination of finasteride (stops the cause) + minoxidil (extends the growth phase) is what the dermatology literature backs as the gold-standard non-surgical regimen.

Topical is the most-studied. Oral 2.5 mg three times a week has equivalent results in recent trials and is much easier to actually use day-to-day. The tradeoff is mild hypertrichosis (extra arm or face hair) in about 8% of people.

Hair regrowth is a slow process and your eyes lie. Standardized photos with our vision model give you a number — density per cm², terminal-to-vellus ratio, shaft diameter. You'll see the trend before you would 'feel' a change in the mirror.

Within 6–12 months of stopping, you'll lose what you grew and revert to your genetic trajectory. Hair restoration is maintenance, not a cure. We'll tell you that up front.

Often yes. Dutasteride blocks both isoenzymes of 5-α reductase and reduces scalp DHT more completely. Trials show ~38% better density gains. It's off-label for hair, requires physician approval, and we usually wait 9–12 months before recommending the switch.

Yes. We don't do procedures, but we coordinate medication around them. Continue fin/min through PRP; pause minoxidil for ~5 days post-microneedling; transplants typically benefit from continued medication to protect the surrounding native hair.

Standardized progress photos at baseline and every 90 days. Your physician reviews the photos alongside your protocol notes. Reproducibility is the main advantage — you and your physician compare the same angles every time.

Yes. The protocol is different (no finasteride; spironolactone or topical minoxidil are first-line) and it's reviewed by a separate dermatology pathway. The intake will route you correctly.

09START THE PROTOCOL

Snap one photo. Watch it come back.

Standardized scalp photo, 4-minute intake, physician review typically same business day. Most members see their first density gain around month 3 and visible regrowth by month 6 — individual results vary.

ASK CLYNE CONCIERGE

Still deciding? Ask the AI.

No signup. No gated form. Get a physician-reviewed answer in under a minute.